Cybin Inc. (CYBN) Fundamentals

Cybin is focused on progressing psychedelic therapeutics by utilizing proprietary drug discovery platforms, innovative drug delivery systems, novel formulation approaches and treatment regimens for psychiatric disorders, all protected under its ever-growing IP portfolio.
SHARE INFORMATION
Market CapUS$ 89 989 625
Shares Outstanding148 530 763
Float164 244 615
Percent Float100,0%
Short Interest0,00
Short Percent Float0,0%
Short Interest Ratio0,00
Short Interest Date-
Latest Fiscal Dividend Per ShareUS$ 0,00
Latest Fiscal RevenueUS$ 1 356 721
Latest Fiscal EPSUS$ 0,00
Latest Fiscal Date2021-03-31
DIVIDENDS
Dividend (3 Years)US$ 0,00
Dividend (5 Years)US$ 0,00
Ex Dividend Date-
Dividend RateUS$ 0,00
Dividend Yield0,0%
Payment Cash-
HOLDERS
Institutions77
Institutional Holdings Date2022-04-30
Institutional Bought Previous 3 Months801 249
Institutional Holdings Percent13,2%
Institutional Sold Previous 3 Months7 978 480
Insider Holdings Date-
Insider Bought Previous 3 Months-
Insider Holdings Percent0,0
Insider Sold Previous 3 Months-
Insider Shares Owned-
TRADING INFO
52 Week HighUS$ 3,38
52 Week LowUS$ 0,42
52 Week High ChangeUS$ -67,39
21 Day Moving AverageUS$ 0,7029
21 Day Extended Moving AverageUS$ 0,678565
50 Day Moving AverageUS$ 0,7799
50 Day Extended Moving AverageUS$ 0,79039
200 Day Moving AverageUS$ 1,539
200 Day Extended Moving AverageUS$ 1,2191
10 Day Average Volume804 258
20 Day Average Volume757 049
30 Day Average Volume809 542
50 Day Average Volume698 191
Alpha0.207235
Beta13.2170
Standard Deviation1.734769
R20.207292
7 Day Price ChangeUS$ -0,0655
7 Day Percent Change-10,68%
21 Day Price ChangeUS$ -0,2587
21 Day Percent Change-32,07%
30 Day Price ChangeUS$ -0,3321
30 Day Percent Change-37,74%
Month to Date Price ChangeUS$ -0,0281
Month to Date Percent Change-4,88%
Quarter to Date Price ChangeUS$ -0,2691
Quarter to Date Percent Change-32,94%
180 Day Price ChangeUS$ -1,56
180 Day Percent Change-74,03%
200 Day Price ChangeUS$ -1,42
200 Day Percent Change-72,19%
Year to Date Price ChangeUS$ -0,6521
Year to Date Percent Change-54,34%

Cybin Inc. (CYBN) Key Ratios

PROFITABILITY
EBIT Margin999 999,99%
EBITDA Margin9 957 892,0%
Pre-Tax Profit Margin0,0%
Profit Margin Count0,0%
Gross Margin23,1%
Profit Margin TOT0,0%
INCOME STATEMENTS
RevenueUS$ 0
Revenue Per ShareUS$ 0,00
Revenue (3 Years)US$ 0,00
Revenue (5 Years)US$ 0,00
FINANCIAL STRENGTH
Price to Tangible Book1,90
Total Debt To Equity0,00
Int Coverage-1 300,10
Current Ratio11,40
Leverage Ratio1,10
Quick Ratio10,80
Long Term Debt To Capital0,00
VALUATION MEASURES
PE Ratio-1,90
Enterprise ValueUS$ 55 486 504
Price to Sales0,00
Price to Free Cash-3,40
PE High Last 5 Years0,00
Price To Book1,40
Price To Cash Flow0,00
PE Low Last 5 Years0,00
Price to Tangible Book1,90
MANAGEMENT EFFECTIVENESS
Receivables Turnover0,00
Invoice Turnover0,00
Assets Turnover0,00
Return Assets-83,35
Return on Equity-91,70
Return on Capital-89,48

Cybin Inc. (CYBN) Profile

PROFILE INFO
Issue TypeCS
SEC Type-
AuditorZeifmans LLP
CEODouglas Drysdale
Emplyoees-
Last AuditUQ
CIK0001833141
IndustryBiotechnology
SectorHealthcare
NAICSResearch and Development in Biotechnology (except Nanobiotechnology)(541714)
CONTACT INFO
Address100 King Street West
Suite 5600
Toronto, ON M5X 1C9
Websitehttps://www.cybin.com
Facsimile-
Telephone+1 908 764-8385
Email-
Dernières Valeurs Consultées
AMEX
CYBN
Cybin
Inscrivez-vous aujourd'hui pour consulter ce titre en streaming sur le Moniteur ADVFN. Vous pourrez ajouter et visualiser jusqu'à 110 des vos actions préférée et c'est complètement gratuit..

Se connecter à ADVFN
S'inscrire maintenant
Les cours EURONEXT (CAC 40, etc. ) et FOREX (les devises) sont en direct si connecté.
NYSE, AMEX, et ASX sont en différé d'environ 20 minutes. Les autres cours sont en différé d'environ 15 minutes.

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

P: V:fr D:20230128 19:10:26